{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:21:35Z","timestamp":1740122495046,"version":"3.37.3"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T00:00:00Z","timestamp":1713744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T00:00:00Z","timestamp":1713744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"DOI":"10.1007\/s11239-024-02975-2","type":"journal-article","created":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T20:29:32Z","timestamp":1713817772000},"page":"852-864","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Overall haemostatic potential assay for prediction of outcomes in venous and arterial thrombosis and thrombo-inflammatory diseases"],"prefix":"10.1007","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2857-6514","authenticated-orcid":false,"given":"Julie","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prahlad","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harshal","family":"Nandurkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui Yin","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,22]]},"reference":[{"key":"2975_CR1","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1161\/circresaha.115.306841","volume":"118","author":"AM Wendelboe","year":"2016","unstructured":"Wendelboe AM, Raskob GE (2016) Global Burden of Thrombosis. Circ Res 118:1340\u20131347. https:\/\/doi.org\/10.1161\/circresaha.115.306841","journal-title":"Circ Res"},{"key":"2975_CR2","doi-asserted-by":"publisher","first-page":"l4363","DOI":"10.1136\/bmj.l4363","volume":"366","author":"F Khan","year":"2019","unstructured":"Khan F, Rahman A, Carrier M et al (2019) Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis. BMJ (Clinical Res ed) 366:l4363. https:\/\/doi.org\/10.1136\/bmj.l4363","journal-title":"BMJ (Clinical Res ed)"},{"key":"2975_CR3","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/s41569-021-00552-1","volume":"18","author":"K Stark","year":"2021","unstructured":"Stark K, Massberg S (2021) Interplay between inflammation and thrombosis in cardiovascular pathology. Nat Rev Cardiol 18:666\u2013682. https:\/\/doi.org\/10.1038\/s41569-021-00552-1","journal-title":"Nat Rev Cardiol"},{"key":"2975_CR4","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","volume":"191","author":"FA Klok","year":"2020","unstructured":"Klok FA, Kruip MJHA, Meer NJM, van der et al (2020) Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res 191:145\u2013147. https:\/\/doi.org\/10.1016\/j.thromres.2020.04.013","journal-title":"Thromb Res"},{"key":"2975_CR5","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1136\/thoraxjnl-2020-215383","volume":"76","author":"BK Tan","year":"2021","unstructured":"Tan BK, Mainbourg S, Friggeri A et al (2021) Arterial and venous thromboembolism in COVID-19: a study-level meta-analysis. Thorax 76:970\u2013979. https:\/\/doi.org\/10.1136\/thoraxjnl-2020-215383","journal-title":"Thorax"},{"key":"2975_CR6","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1152\/physrev.00016.2011","volume":"93","author":"HH Versteeg","year":"2013","unstructured":"Versteeg HH, Heemskerk JWM, Levi M, Reitsma PH (2013) New fundamentals in Hemostasis. Physiol Rev 93:327\u2013358. https:\/\/doi.org\/10.1152\/physrev.00016.2011","journal-title":"Physiol Rev"},{"key":"2975_CR7","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s11239-021-02621-1","volume":"54","author":"HY Lim","year":"2022","unstructured":"Lim HY, Donnan G, Nandurkar H, Ho P (2022) Global coagulation assays in hypercoagulable states. J Thromb Thrombolys 54:132\u2013144. https:\/\/doi.org\/10.1007\/s11239-021-02621-1","journal-title":"J Thromb Thrombolys"},{"key":"2975_CR8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.thromres.2019.04.033","volume":"179","author":"HY Lim","year":"2019","unstructured":"Lim HY, O\u2019Malley C, Donnan G et al (2019) A review of global coagulation assays \u2014 is there a role in thrombosis risk prediction? Thromb Res 179:45\u201355. https:\/\/doi.org\/10.1016\/j.thromres.2019.04.033","journal-title":"Thromb Res"},{"key":"2975_CR9","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1373\/clinchem.2008.112243","volume":"54","author":"S Eichinger","year":"2008","unstructured":"Eichinger S, Hron G, Kollars M, Kyrle PA (2008) Prediction of recurrent venous thromboembolism by endogenous thrombin potential and D-dimer. Clin Chem 54:2042\u20132048. https:\/\/doi.org\/10.1373\/clinchem.2008.112243","journal-title":"Clin Chem"},{"key":"2975_CR10","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1111\/j.1538-7836.2008.03018.x","volume":"6","author":"A Tripodi","year":"2008","unstructured":"Tripodi A, Legnani C, Chantarangkul V et al (2008) High thrombin generation measured in the presence of thrombomodulin is associated with an increased risk of recurrent venous thromboembolism. J Thromb Haemost 6:1327\u20131333. https:\/\/doi.org\/10.1111\/j.1538-7836.2008.03018.x","journal-title":"J Thromb Haemost"},{"key":"2975_CR11","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1182\/blood-2012-08-378935","volume":"121","author":"G Young","year":"2013","unstructured":"Young G, S\u00f8rensen B, Dargaud Y et al (2013) Thrombin generation and whole blood viscoelastic assays in the management of hemophilia: current state of art and future perspectives. Blood 121:1944\u20131950. https:\/\/doi.org\/10.1182\/blood-2012-08-378935","journal-title":"Blood"},{"key":"2975_CR12","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.thromres.2023.04.016","volume":"226","author":"HY Lim","year":"2023","unstructured":"Lim HY, Lui B, Tacey M et al (2023) Global coagulation assays in patients with chronic kidney disease and their role in predicting thrombotic risk. Thromb Res 226:127\u2013135. https:\/\/doi.org\/10.1016\/j.thromres.2023.04.016","journal-title":"Thromb Res"},{"key":"2975_CR13","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s11239-022-02686-6","volume":"55","author":"J Wang","year":"2022","unstructured":"Wang J, Lim HY, Brook R et al (2022) Overall haemostatic potential (OHP) assay can risk stratify for venous thromboembolism recurrence in anticoagulated patients. J Thromb Thrombolysis 55:32\u201341. https:\/\/doi.org\/10.1007\/s11239-022-02686-6","journal-title":"J Thromb Thrombolysis"},{"key":"2975_CR14","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.3390\/jpm12101711","volume":"12","author":"J Wang","year":"2022","unstructured":"Wang J, Choy KW, Lim HY, Ho P (2022) Impaired fibrinolytic potential predicts Oxygen requirement in COVID-19. J Personalized Med 12:1711. https:\/\/doi.org\/10.3390\/jpm12101711","journal-title":"J Personalized Med"},{"key":"2975_CR15","first-page":"1087","volume":"134","author":"TA Drake","year":"1989","unstructured":"Drake TA, Morrissey JH, Edgington TS (1989) Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol 134:1087\u20131097","journal-title":"Am J Pathol"},{"key":"2975_CR16","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.bcmd.2005.12.034","volume":"36","author":"KG Mann","year":"2006","unstructured":"Mann KG, Brummel-Ziedins K, Orfeo T, Butenas S (2006) Models of blood coagulation. Blood Cells Mol Dis 36:108\u2013117. https:\/\/doi.org\/10.1016\/j.bcmd.2005.12.034","journal-title":"Blood Cells Mol Dis"},{"key":"2975_CR17","doi-asserted-by":"publisher","first-page":"100023","DOI":"10.1016\/j.rpth.2022.100023","volume":"7","author":"RI Litvinov","year":"2023","unstructured":"Litvinov RI, Weisel JW (2023) Blood clot contraction: mechanisms, pathophysiology, and disease. Res Pr Thromb Haemost 7:100023. https:\/\/doi.org\/10.1016\/j.rpth.2022.100023","journal-title":"Res Pr Thromb Haemost"},{"key":"2975_CR18","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1161\/atvbaha.108.162289","volume":"28","author":"TW Wakefield","year":"2008","unstructured":"Wakefield TW, Myers DD, Henke PK, Arter (2008) Thromb Vasc Biol 28:387\u2013391. https:\/\/doi.org\/10.1161\/atvbaha.108.162289","journal-title":"Thromb Vasc Biol"},{"key":"2975_CR19","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/jth.14360","volume":"17","author":"JW Weisel","year":"2019","unstructured":"Weisel JW, Litvinov RI (2019) Red blood cells: the forgotten player in hemostasis and thrombosis. J Thromb Haemost 17:271\u2013282. https:\/\/doi.org\/10.1111\/jth.14360","journal-title":"J Thromb Haemost"},{"key":"2975_CR20","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/s0065-3233(05)70008-5","volume":"70","author":"JW Weisel","year":"2005","unstructured":"Weisel JW (2005) Fibrinogen and fibrin. Adv Protein Chem 70:247\u2013299. https:\/\/doi.org\/10.1016\/s0065-3233(05)70008-5","journal-title":"Adv Protein Chem"},{"key":"2975_CR21","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1160\/th14-01-0032","volume":"112","author":"A Undas","year":"2014","unstructured":"Undas A (2014) Fibrin clot properties and their modulation in thrombotic disorders. Thromb Haemostasis 112:32\u201342. https:\/\/doi.org\/10.1160\/th14-01-0032","journal-title":"Thromb Haemostasis"},{"key":"2975_CR22","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1248\/bpb.18.203","volume":"18","author":"M Okude","year":"1995","unstructured":"Okude M, Yamanaka A, Akihama S (1995) The effects of pH on the generation of turbidity and elasticity Associated with Fibrinogen-Fibrin Conversion by Thrombin are remarkably influenced by Sialic Acid in Fibrinogen. Biol Pharm Bull 18:203\u2013207. https:\/\/doi.org\/10.1248\/bpb.18.203","journal-title":"Biol Pharm Bull"},{"key":"2975_CR23","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/0049-3848(86)90117-9","volume":"42","author":"CH Nair","year":"1986","unstructured":"Nair CH, Shah GA, Dhall DP (1986) Effect of temperature, Ph and ionic strength and composition on fibrin network structure and its development. Thromb Res 42:809\u2013816. https:\/\/doi.org\/10.1016\/0049-3848(86)90117-9","journal-title":"Thromb Res"},{"key":"2975_CR24","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/0049-3848(83)90039-7","volume":"29","author":"M Okada","year":"1983","unstructured":"Okada M, Blomb\u00e4ck B (1983) Calcium and fibrin gel structure. Thromb Res 29:269\u2013280. https:\/\/doi.org\/10.1016\/0049-3848(83)90039-7","journal-title":"Thromb Res"},{"key":"2975_CR25","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/s0022-2143(96)90116-x","volume":"128","author":"ME Carr","year":"1996","unstructured":"Carr ME, Dent RM, Carr SL (1996) Abnormal fibrin structure and inhibition of fibrinolysis in patients with multiple myeloma. J Lab Clin Med 128:83\u201388. https:\/\/doi.org\/10.1016\/s0022-2143(96)90116-x","journal-title":"J Lab Clin Med"},{"key":"2975_CR26","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1182\/blood-2013-08-523860","volume":"123","author":"DB Cines","year":"2014","unstructured":"Cines DB, Lebedeva T, Nagaswami C et al (2014) Clot contraction: compression of erythrocytes into tightly packed polyhedra and redistribution of platelets and fibrin. Blood 123:1596\u20131603. https:\/\/doi.org\/10.1182\/blood-2013-08-523860","journal-title":"Blood"},{"key":"2975_CR27","doi-asserted-by":"publisher","first-page":"17611","DOI":"10.1038\/srep17611","volume":"5","author":"LD Zubairova","year":"2015","unstructured":"Zubairova LD, Nabiullina RM, Nagaswami C et al (2015) Circulating microparticles alter formation, structure and Properties of Fibrin Clots. Sci Rep-uk 5:17611. https:\/\/doi.org\/10.1038\/srep17611","journal-title":"Sci Rep-uk"},{"key":"2975_CR28","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1161\/atvbaha.115.306035","volume":"35","author":"TJ Gould","year":"2018","unstructured":"Gould TJ, Vu TT, Stafford AR et al (2018) Cell-free DNA modulates clot structure and impairs Fibrinolysis in Sepsis. Arterioscler Thromb Vasc Biology 35:2544\u20132553. https:\/\/doi.org\/10.1161\/atvbaha.115.306035","journal-title":"Arterioscler Thromb Vasc Biology"},{"key":"2975_CR29","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1055\/s-0036-1572353","volume":"42","author":"F Macrae","year":"2016","unstructured":"Macrae F, Domingues M, Casini A, Ari\u00ebns R (2016) The (patho)physiology of Fibrinogen \u03b3\u2032. Seminars Thromb Hemost 42:344\u2013355. https:\/\/doi.org\/10.1055\/s-0036-1572353","journal-title":"Seminars Thromb Hemost"},{"key":"2975_CR30","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1161\/atvbaha.119.313626","volume":"40","author":"JJ de Vries","year":"2019","unstructured":"de Vries JJ, Snoek CJM, Rijken DC, de Maat MPM (2019) Effects of post-translational modifications of fibrinogen on clot formation, clot structure, and Fibrinolysis. Arterioscler Thromb Vasc Biology 40:554\u2013569. https:\/\/doi.org\/10.1161\/atvbaha.119.313626","journal-title":"Arterioscler Thromb Vasc Biology"},{"key":"2975_CR31","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/j.1538-7836.2007.02464.x","volume":"5","author":"RL Medcalf","year":"2007","unstructured":"Medcalf RL (2007) Fibrinolysis, inflammation, and regulation of the plasminogen activating system. J Thromb Haemost 5:132\u2013142. https:\/\/doi.org\/10.1111\/j.1538-7836.2007.02464.x","journal-title":"J Thromb Haemost"},{"key":"2975_CR32","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/j.1365-2141.2005.05444.x","volume":"129","author":"G Cesarman-Maus","year":"2005","unstructured":"Cesarman-Maus G, Hajjar KA (2005) Molecular mechanisms of fibrinolysis. Brit J Haematol 129:307\u2013321. https:\/\/doi.org\/10.1111\/j.1365-2141.2005.05444.x","journal-title":"Brit J Haematol"},{"key":"2975_CR33","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1161\/01.atv.20.5.1354","volume":"20","author":"JP Collet","year":"2000","unstructured":"Collet JP, Park D, Lesty C et al (2000) Influence of Fibrin Network Conformation and Fibrin Fiber Diameter on Fibrinolysis Speed. Arterioscler Thromb Vasc Biology 20:1354\u20131361. https:\/\/doi.org\/10.1161\/01.atv.20.5.1354","journal-title":"Arterioscler Thromb Vasc Biology"},{"key":"2975_CR34","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1161\/circresaha.116.306853","volume":"118","author":"JH Foley","year":"2016","unstructured":"Foley JH, Conway EM (2016) Cross Talk pathways between Coagulation and inflammation. Circ Res 118:1392\u20131408. https:\/\/doi.org\/10.1161\/circresaha.116.306853","journal-title":"Circ Res"},{"key":"2975_CR35","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.2337\/diabetes.51.4.1131","volume":"51","author":"A Festa","year":"2002","unstructured":"Festa A, D\u2019Agostino R, Tracy RP et al (2002) Elevated Levels of Acute-Phase Proteins and Plasminogen Activator Inhibitor-1 predict the development of type 2 diabetes. Diabetes 51:1131\u20131137. https:\/\/doi.org\/10.2337\/diabetes.51.4.1131","journal-title":"Diabetes"},{"key":"2975_CR36","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/j.jacc.2015.02.040","volume":"65","author":"ON Okafor","year":"2015","unstructured":"Okafor ON, Gorog DA (2015) Endogenous fibrinolysis an important mediator of Thrombus formation and Cardiovascular Risk. J Am Coll Cardiol 65:1683\u20131699. https:\/\/doi.org\/10.1016\/j.jacc.2015.02.040","journal-title":"J Am Coll Cardiol"},{"key":"2975_CR37","doi-asserted-by":"publisher","first-page":"9I","DOI":"10.1161\/01.cir.0000078469.07362.e6","volume":"107","author":"FAA Spencer Jr","year":"2003","unstructured":"Spencer FAA Jr. FA (2003) Risk factors for venous thromboembolism. Circulation 107:9I\u201316. https:\/\/doi.org\/10.1161\/01.cir.0000078469.07362.e6","journal-title":"Circulation"},{"key":"2975_CR38","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1111\/j.1538-7836.2009.03293.x","volume":"7","author":"E Bruinstroop","year":"2009","unstructured":"Bruinstroop E, Klok FA, Ree MAVD et al (2009) Elevated D-dimer levels predict recurrence in patients with idiopathic venous thromboembolism: a meta-analysis. J Thromb Haemost 7:611\u2013618. https:\/\/doi.org\/10.1111\/j.1538-7836.2009.03293.x","journal-title":"J Thromb Haemost"},{"key":"2975_CR39","doi-asserted-by":"publisher","first-page":"3073","DOI":"10.1093\/eurheartj\/ehad417","volume":"44","author":"N van Es","year":"2023","unstructured":"van Es N, Takada T, Kraaijpoel N et al (2023) Diagnostic management of acute pulmonary embolism: a prediction model based on a patient data meta-analysis. Eur Hear J 44:3073\u20133081. https:\/\/doi.org\/10.1093\/eurheartj\/ehad417","journal-title":"Eur Hear J"},{"key":"2975_CR40","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1111\/j.1538-7836.2012.04735.x","volume":"10","author":"A Tosetto","year":"2012","unstructured":"Tosetto A, Iorio A, Marcucci M et al (2012) Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH). J Thromb Haemost 10:1019\u20131025. https:\/\/doi.org\/10.1111\/j.1538-7836.2012.04735.x","journal-title":"J Thromb Haemost"},{"key":"2975_CR41","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1161\/circulationaha.109.925214","volume":"121","author":"S Eichinger","year":"2010","unstructured":"Eichinger S, Heinze G, Jandeck LM, Kyrle PA (2010) Risk Assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism. Circulation 121:1630\u20131636. https:\/\/doi.org\/10.1161\/circulationaha.109.925214","journal-title":"Circulation"},{"key":"2975_CR42","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3390\/hemato2010003","volume":"2","author":"J Wang","year":"2021","unstructured":"Wang J, Lim HY, Ho P (2021) Individualised risk assessments for recurrent venous thromboembolism: New frontiers in the era of direct oral anticoagulants. Hemato 2:64\u201378. https:\/\/doi.org\/10.3390\/hemato2010003","journal-title":"Hemato"},{"key":"2975_CR43","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1016\/j.jacc.2017.09.024","volume":"70","author":"JI Weitz","year":"2017","unstructured":"Weitz JI, Fredenburgh JC, Eikelboom JW (2017) A test in Context: D-Dimer. J Am Coll Cardiol 70:2411\u20132420. https:\/\/doi.org\/10.1016\/j.jacc.2017.09.024","journal-title":"J Am Coll Cardiol"},{"key":"2975_CR44","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.annemergmed.2022.09.014","volume":"81","author":"K de Wit","year":"2023","unstructured":"de Wit K, Al-Haimus F, Hu Y et al (2023) Comparison of YEARS and adjust-unlikely D-dimer testing for Pulmonary Embolism in the Emergency Department. Ann Emerg Med 81:558\u2013565. https:\/\/doi.org\/10.1016\/j.annemergmed.2022.09.014","journal-title":"Ann Emerg Med"},{"key":"2975_CR45","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1182\/blood-2014-01-548065","volume":"124","author":"G Palareti","year":"2014","unstructured":"Palareti G, Cosmi B, Legnani C et al (2014) D-dimer to guide the duration of anticoagulation in patients with venous thromboembolism: a management study. Blood 124:196\u2013203. https:\/\/doi.org\/10.1182\/blood-2014-01-548065","journal-title":"Blood"},{"key":"2975_CR46","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.7326\/m21-1094","volume":"174","author":"F Khan","year":"2021","unstructured":"Khan F, Tritschler T, Kimpton M et al (2021) Long-term risk for major bleeding during extended oral anticoagulant therapy for first unprovoked venous thromboembolism: a systematic review and Meta-analysis. Ann Intern Med 174:1420\u20131429. https:\/\/doi.org\/10.7326\/m21-1094","journal-title":"Ann Intern Med"},{"key":"2975_CR47","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1160\/th13-01-0032","volume":"110","author":"M-C Kleinegris","year":"2013","unstructured":"Kleinegris M-C, Cate H, ten Cate-Hoek A (2013) D-dimer as a marker for cardiovascular and arterial thrombotic events in patients with peripheral arterial disease. Thromb Haemost 110:233\u2013243. https:\/\/doi.org\/10.1160\/th13-01-0032","journal-title":"Thromb Haemost"},{"key":"2975_CR48","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1111\/jth.13957","volume":"16","author":"C Longstaff","year":"2018","unstructured":"Longstaff C (2018) Measuring fibrinolysis: from research to routine diagnostic assays. J Thromb Haemost 16:652\u2013662. https:\/\/doi.org\/10.1111\/jth.13957","journal-title":"J Thromb Haemost"},{"key":"2975_CR49","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1182\/blood-2010-02-267740","volume":"116","author":"ME Meltzer","year":"2010","unstructured":"Meltzer ME, Lisman T, de Groot PG et al (2010) Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1. Blood 116:113\u2013121. https:\/\/doi.org\/10.1182\/blood-2010-02-267740","journal-title":"Blood"},{"key":"2975_CR50","doi-asserted-by":"publisher","first-page":"807","DOI":"10.3390\/biom12060807","volume":"12","author":"HA Belcher","year":"2022","unstructured":"Belcher HA, Litwa K, Guthold M, Hudson NE (2022) The applicability of current turbidimetric approaches for analyzing fibrin fibers and other Filamentous Networks. Biomolecules 12:807. https:\/\/doi.org\/10.3390\/biom12060807","journal-title":"Biomolecules"},{"key":"2975_CR51","doi-asserted-by":"publisher","first-page":"063","DOI":"10.1055\/s-0040-1718888","volume":"47","author":"S He","year":"2020","unstructured":"He S, Cao H, Th\u00e5lin C et al (2020) The clotting trigger is an important determinant for the Coagulation pathway in vivo or in Vitro\u2014Inference from Data Review. Semin Thromb Hemost 47:063\u2013073. https:\/\/doi.org\/10.1055\/s-0040-1718888","journal-title":"Semin Thromb Hemost"},{"key":"2975_CR52","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1097\/00001721-200209000-00008","volume":"13","author":"AS Wolberg","year":"2002","unstructured":"Wolberg AS, Gabriel DA, Hoffman M (2002) Analyzing fibrin clot structure using a microplate reader. Blood Coagul Fibrin 13:533\u2013539. https:\/\/doi.org\/10.1097\/00001721-200209000-00008","journal-title":"Blood Coagul Fibrin"},{"key":"2975_CR53","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/s0049-3848(99)00092-4","volume":"96","author":"S He","year":"1999","unstructured":"He S, Bremme K, Blomb\u00e4ck M (1999) A Laboratory Method for determination of overall haemostatic potential in plasma. I. Method Design and preliminary results. Thromb Res 96:145\u2013156. https:\/\/doi.org\/10.1016\/s0049-3848(99)00092-4","journal-title":"Thromb Res"},{"key":"2975_CR54","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/mbc.0000000000001115","volume":"33","author":"J Wang","year":"2022","unstructured":"Wang J, Lim HY, Nandurkar H, Ho P (2022) Age, sex and racial differences in fibrin formation and fibrinolysis within the healthy population. Blood Coagul Fibrin 33:141\u2013144. https:\/\/doi.org\/10.1097\/mbc.0000000000001115","journal-title":"Blood Coagul Fibrin"},{"key":"2975_CR55","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1160\/TH06-07-0370","volume":"98","author":"S He","year":"2007","unstructured":"He S, Zhu K, Skeppholm M et al (2007) A global assay of haemostasis which uses recombinant tissue factor and tissue-type plasminogen activator to measure the rate of fibrin formation and fibrin degradation in plasma. Thromb Haemostasis 98:871\u2013882","journal-title":"Thromb Haemostasis"},{"key":"2975_CR56","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/j.1538-7836.2007.02362.x","volume":"5","author":"JL Curnow","year":"2007","unstructured":"Curnow JL, Morel-Kopp M\u2010C., Roddie C et al (2007) Reduced fibrinolysis and increased fibrin generation can be detected in hypercoagulable patients using the overall hemostatic potential assay. J Thromb Haemost 5:528\u2013534. https:\/\/doi.org\/10.1111\/j.1538-7836.2007.02362.x","journal-title":"J Thromb Haemost"},{"key":"2975_CR57","doi-asserted-by":"publisher","unstructured":"He S, Antovic A, research MBT (2001) (2001) A simple and rapid laboratory method for determination of haemostasis potential in plasma: II. Modifications for use in routine laboratories and research work. Elsevier 103:355\u2013361. https:\/\/doi.org\/10.1016\/s0049-3848(01)00332-2","DOI":"10.1016\/s0049-3848(01)00332-2"},{"key":"2975_CR58","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1742-4933-5-12","volume":"5","author":"D Mari","year":"2008","unstructured":"Mari D, Ogliari G, Castaldi D et al (2008) Hemostasis and ageing. Immun Ageing 5:12. https:\/\/doi.org\/10.1186\/1742-4933-5-12","journal-title":"Immun Ageing"},{"key":"2975_CR59","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s41569-018-0064-2","volume":"15","author":"L Ferrucci","year":"2018","unstructured":"Ferrucci L, Fabbri E (2018) Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol 15:505\u2013522. https:\/\/doi.org\/10.1038\/s41569-018-0064-2","journal-title":"Nat Rev Cardiol"},{"key":"2975_CR60","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1161\/hq0202.102318","volume":"22","author":"FR Rosendaal","year":"2002","unstructured":"Rosendaal FR, Helmerhorst FM, Vandenbroucke JP (2002) Female hormones and thrombosis. Arterioscler Thromb Vasc Biology 22:201\u2013210. https:\/\/doi.org\/10.1161\/hq0202.102318","journal-title":"Arterioscler Thromb Vasc Biology"},{"key":"2975_CR61","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/1047-2797(92)90095-8","volume":"2","author":"WB Kannel","year":"1992","unstructured":"Kannel WB, D\u2019Agostino RB, Belanger AJ (1992) Update on fibrinogen as a cardiovascular risk factor. Ann Epidemiol 2:457\u2013466. https:\/\/doi.org\/10.1016\/1047-2797(92)90095-8","journal-title":"Ann Epidemiol"},{"key":"2975_CR62","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1055\/s-0037-1613959","volume":"84","author":"J Meijers","year":"2000","unstructured":"Meijers J, Middeldorp S, Tekelenburg W et al (2000) Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down Regulation of Fibrinolysis. Thromb Haemostasis 84:9\u201314. https:\/\/doi.org\/10.1055\/s-0037-1613959","journal-title":"Thromb Haemostasis"},{"key":"2975_CR63","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s10654-021-00813-w","volume":"37","author":"CAL Arnesen","year":"2022","unstructured":"Arnesen CAL, Veres K, Horv\u00e1th-Puh\u00f3 E et al (2022) Estimated lifetime risk of venous thromboembolism in men and women in a Danish nationwide cohort: impact of competing risk of death. Eur J Epidemiol 37:195\u2013203. https:\/\/doi.org\/10.1007\/s10654-021-00813-w","journal-title":"Eur J Epidemiol"},{"key":"2975_CR64","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.expneurol.2014.02.011","volume":"259","author":"M Roy-O\u2019Reilly","year":"2014","unstructured":"Roy-O\u2019Reilly M, McCullough LD (2014) Sex differences in stroke: the contribution of coagulation. Exp Neurol 259:16\u201327. https:\/\/doi.org\/10.1016\/j.expneurol.2014.02.011","journal-title":"Exp Neurol"},{"key":"2975_CR65","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.3390\/diagnostics12123165","volume":"12","author":"B McLeod","year":"2022","unstructured":"McLeod B, Lim HY, Nandurkar H et al (2022) Overall hemostatic potential assay detects risk of progression to post-thrombotic syndrome in anticoagulated patients following deep vein thrombosis. Diagnostics 12:3165. https:\/\/doi.org\/10.3390\/diagnostics12123165","journal-title":"Diagnostics"},{"key":"2975_CR66","doi-asserted-by":"publisher","first-page":"e12611","DOI":"10.1002\/rth2.12611","volume":"5","author":"HY Lim","year":"2021","unstructured":"Lim HY, Lui B, Tacey M et al (2021) Global coagulation assays in patients with diabetes mellitus. Res Pract Thromb Haemostasis 5:e12611. https:\/\/doi.org\/10.1002\/rth2.12611","journal-title":"Res Pract Thromb Haemostasis"},{"key":"2975_CR67","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1097\/mbc.0000000000000285","volume":"26","author":"V Chow","year":"2015","unstructured":"Chow V, Reddel C, Pennings G et al (2015) Persistent global hypercoagulability in long-term survivors of acute pulmonary embolism. Blood Coagul Fibrin 26:537\u2013544. https:\/\/doi.org\/10.1097\/mbc.0000000000000285","journal-title":"Blood Coagul Fibrin"},{"key":"2975_CR68","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1111\/j.1538-7836.2003.00451.x","volume":"1","author":"A Antovic","year":"2003","unstructured":"Antovic A, Blomb\u00e4ck M, Bremme K et al (2003) Increased hemostasis potential persists in women with previous thromboembolism with or without APC resistance. J Thromb Haemost 1:2531\u20132535. https:\/\/doi.org\/10.1111\/j.1538-7836.2003.00451.x","journal-title":"J Thromb Haemost"},{"key":"2975_CR69","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.cjca.2019.08.001","volume":"36","author":"L Drabik","year":"2020","unstructured":"Drabik L, Konieczy\u0144ska M, Undas A (2020) Clot lysis time predicts Stroke during Anticoagulant Therapy in patients with Atrial Fibrillation. Can J Cardiol 36:119\u2013126. https:\/\/doi.org\/10.1016\/j.cjca.2019.08.001","journal-title":"Can J Cardiol"},{"key":"2975_CR70","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.14020","author":"J Wang","year":"2023","unstructured":"Wang J, Lim HY, Nandurkar H, Ho P (2023) DOAC-stop can remove direct oral anticoagulants and allow analysis by global coagulation assays. Int J Lab Hematol. https:\/\/doi.org\/10.1111\/ijlh.14020","journal-title":"Int J Lab Hematol"},{"key":"2975_CR71","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1182\/asheducation-2016.1.413","volume":"2016","author":"SR Kahn","year":"2016","unstructured":"Kahn SR (2016) The post-thrombotic syndrome. Hematology 2016:413\u2013418. https:\/\/doi.org\/10.1182\/asheducation-2016.1.413","journal-title":"Hematology"},{"key":"2975_CR72","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/j.1600-0609.2011.01733.x","volume":"88","author":"P Prandoni","year":"2012","unstructured":"Prandoni P (2012) Healthcare burden associated with the post-thrombotic syndrome and potential impact of the new oral anticoagulants. Eur J Haematol 88:185\u2013194. https:\/\/doi.org\/10.1111\/j.1600-0609.2011.01733.x","journal-title":"Eur J Haematol"},{"key":"2975_CR73","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/s0140-6736(13)61902-9","volume":"383","author":"SR Kahn","year":"2014","unstructured":"Kahn SR, Shapiro S, Wells PS et al (2014) Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial. Lancet 383:880\u2013888. https:\/\/doi.org\/10.1016\/s0140-6736(13)61902-9","journal-title":"Lancet"},{"key":"2975_CR74","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1056\/nejmoa1615066","volume":"377","author":"S Vedantham","year":"2017","unstructured":"Vedantham S, Goldhaber SZ, Julian JA et al (2017) Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis. New Engl J Med 377:2240\u20132252. https:\/\/doi.org\/10.1056\/nejmoa1615066","journal-title":"New Engl J Med"},{"key":"2975_CR75","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1055\/s-0039-1677795","volume":"119","author":"C Kearon","year":"2019","unstructured":"Kearon C, Gu C-S, Julian J et al (2019) Pharmacomechanical Catheter-Directed Thrombolysis in Acute femoral\u2013popliteal deep vein thrombosis: analysis from a stratified Randomized Trial. Thromb Haemostasis 119:633\u2013644. https:\/\/doi.org\/10.1055\/s-0039-1677795","journal-title":"Thromb Haemostasis"},{"key":"2975_CR76","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1161\/atvbaha.117.308564","volume":"37","author":"S Kattula","year":"2018","unstructured":"Kattula S, Byrnes JR, Wolberg AS (2018) Fibrinogen and fibrin in Hemostasis and thrombosis. Arterioscler Thromb Vasc Biology 37:e13\u2013e21. https:\/\/doi.org\/10.1161\/atvbaha.117.308564","journal-title":"Arterioscler Thromb Vasc Biology"},{"key":"2975_CR77","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1093\/eurheartj\/ehy013","volume":"39","author":"W Sumaya","year":"2018","unstructured":"Sumaya W, Wallentin L, James SK et al (2018) Fibrin clot properties independently predict adverse clinical outcome following acute coronary syndrome: a PLATO substudy. Eur Hear J 39:1078\u20131085. https:\/\/doi.org\/10.1093\/eurheartj\/ehy013","journal-title":"Eur Hear J"},{"key":"2975_CR78","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1093\/eurheartj\/ehy656","volume":"40","author":"M Farag","year":"2018","unstructured":"Farag M, Spinthakis N, Gue YX et al (2018) Impaired endogenous fibrinolysis in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention is a predictor of recurrent cardiovascular events: the RISK PPCI study. Eur Heart J 40:295\u2013305. https:\/\/doi.org\/10.1093\/eurheartj\/ehy656","journal-title":"Eur Heart J"},{"key":"2975_CR79","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1055\/s-0037-1615594","volume":"85","author":"MA Crowther","year":"2001","unstructured":"Crowther MA, Roberts J, Roberts R et al (2001) Fibrinolytic variables in patients with recurrent venous thrombosis: a prospective cohort study. Thromb Haemostasis 85:390\u2013394","journal-title":"Thromb Haemostasis"},{"key":"2975_CR80","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1055\/s-0041-1725094","volume":"47","author":"A Undas","year":"2021","unstructured":"Undas A (2021) Fibrinolysis in venous thromboembolism. Semin Thromb Hemost 47:480\u2013489. https:\/\/doi.org\/10.1055\/s-0041-1725094","journal-title":"Semin Thromb Hemost"},{"key":"2975_CR81","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1016\/j.jacc.2019.07.030","volume":"74","author":"DA Gorog","year":"2019","unstructured":"Gorog DA, Lip GYH (2019) Impaired Spontaneous\/Endogenous fibrinolytic status as New Cardiovascular Risk factor? JACC Review Topic of the Week. J Am Coll Cardiol 74:1366\u20131375. https:\/\/doi.org\/10.1016\/j.jacc.2019.07.030","journal-title":"J Am Coll Cardiol"},{"key":"2975_CR82","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/ejh.12992","volume":"100","author":"Y Harahsheh","year":"2018","unstructured":"Harahsheh Y, Ho KM (2018) Use of viscoelastic tests to predict clinical thromboembolic events: a systematic review and meta-analysis. Eur J Haematol 100:113\u2013123. https:\/\/doi.org\/10.1111\/ejh.12992","journal-title":"Eur J Haematol"},{"key":"2975_CR83","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/01.mbc.0000046170.06450.9b","volume":"14","author":"J Yamamoto","year":"2003","unstructured":"Yamamoto J, Yamashita T, Ikarugi H et al (2003) G\u00f6r\u00f6g thrombosis test. Blood Coagul Fibrinolysis 14:31\u201339. https:\/\/doi.org\/10.1097\/01.mbc.0000046170.06450.9b","journal-title":"Blood Coagul Fibrinolysis"},{"key":"2975_CR84","doi-asserted-by":"publisher","first-page":"e12706","DOI":"10.1002\/rth2.12706","volume":"6","author":"F Edfors","year":"2022","unstructured":"Edfors F, Iglesias MJ, Butler LM, Odeberg J (2022) Proteomics in thrombosis research. Res Pr Thromb Haemost 6:e12706. https:\/\/doi.org\/10.1002\/rth2.12706","journal-title":"Res Pr Thromb Haemost"},{"key":"2975_CR85","doi-asserted-by":"publisher","first-page":"100011","DOI":"10.1016\/j.tru.2020.100011","volume":"1","author":"M Quintero","year":"2020","unstructured":"Quintero M, Tasic L, Annichino-Bizzacchi JM (2020) Thrombosis: current knowledge based on metabolomics by nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS). Thromb Updat 1:100011. https:\/\/doi.org\/10.1016\/j.tru.2020.100011","journal-title":"Thromb Updat"},{"key":"2975_CR86","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1177\/0003702816686593","volume":"71","author":"CG Atkins","year":"2016","unstructured":"Atkins CG, Buckley K, Blades MW, Turner RFB (2016) Raman Spectroscopy of Blood and Blood Components. Appl Spectrosc 71:767\u2013793. https:\/\/doi.org\/10.1177\/0003702816686593","journal-title":"Appl Spectrosc"},{"key":"2975_CR87","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/0167-4838(89)90140-4","volume":"997","author":"B Blomb\u00e4ck","year":"1989","unstructured":"Blomb\u00e4ck B, Carlsson K, Hessel B et al (1989) Native fibrin gel networks observed by 3D microscopy, permeation and turbidity. Biochim Et Biophys Acta Bba - Protein Struct Mol Enzym 997:96\u2013110. https:\/\/doi.org\/10.1016\/0167-4838(89)90140-4","journal-title":"Biochim Et Biophys Acta Bba - Protein Struct Mol Enzym"},{"key":"2975_CR88","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1111\/jth.13278","volume":"14","author":"GCG Hugenholtz","year":"2016","unstructured":"Hugenholtz GCG, Macrae F, Adelmeijer J et al (2016) Procoagulant changes in fibrin clot structure in patients with cirrhosis are associated with oxidative modifications of fibrinogen. J Thromb Haemost 14:1054\u20131066. https:\/\/doi.org\/10.1111\/jth.13278","journal-title":"J Thromb Haemost"},{"key":"2975_CR89","doi-asserted-by":"publisher","first-page":"737","DOI":"10.3390\/antiox9080737","volume":"9","author":"M Becatti","year":"2020","unstructured":"Becatti M, Mannucci A, Argento FR et al (2020) Super-resolution Microscopy reveals an altered Fibrin Network in cirrhosis: the key role of oxidative stress in fibrinogen structural modifications. Antioxidants 9:737. https:\/\/doi.org\/10.3390\/antiox9080737","journal-title":"Antioxidants"},{"key":"2975_CR90","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41577-021-00536-9","volume":"21","author":"A Bonaventura","year":"2021","unstructured":"Bonaventura A, Vecchi\u00e9 A, Dagna L et al (2021) Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. Nat Rev Immunol 21:319\u2013329. https:\/\/doi.org\/10.1038\/s41577-021-00536-9","journal-title":"Nat Rev Immunol"},{"key":"2975_CR91","doi-asserted-by":"publisher","first-page":"NEJMoa2105911","DOI":"10.1056\/nejmoa2105911","volume":"385","author":"A Investigators","year":"2021","unstructured":"Investigators A, Investigators A- 4a, Investigators R-C et al (2021) Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19. New Engl J Med 385:NEJMoa2105911. https:\/\/doi.org\/10.1056\/nejmoa2105911","journal-title":"New Engl J Med"},{"key":"2975_CR92","doi-asserted-by":"publisher","unstructured":"Spyropoulos AC, Goldin M, Giannis D et al (2021) Efficacy and safety of therapeutic-dose heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk hospitalized patients with COVID-19. Jama Intern Med 181. https:\/\/doi.org\/10.1001\/jamainternmed.2021.6203","DOI":"10.1001\/jamainternmed.2021.6203"},{"key":"2975_CR93","doi-asserted-by":"publisher","first-page":"n2400","DOI":"10.1136\/bmj.n2400","volume":"375","author":"M Sholzberg","year":"2021","unstructured":"Sholzberg M, Tang GH, Rahhal H et al (2021) Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial. BMJ 375:n2400. https:\/\/doi.org\/10.1136\/bmj.n2400","journal-title":"BMJ"},{"key":"2975_CR94","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1055\/s-0038-1666859","volume":"118","author":"CEA Dronkers","year":"2018","unstructured":"Dronkers CEA, Mol GC, Maraziti G et al (2018) Predicting Post-thrombotic Syndrome with Ultrasonographic Follow-Up after deep vein thrombosis: a systematic review and Meta-analysis. Thromb Haemostasis 118:1428\u20131438. https:\/\/doi.org\/10.1055\/s-0038-1666859","journal-title":"Thromb Haemostasis"},{"key":"2975_CR95","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1056\/nejmra055289","volume":"355","author":"JJ Bergan","year":"2006","unstructured":"Bergan JJ, Schmid-Sch\u00f6nbein GW, Smith PDC et al (2006) Chronic venous disease. New Engl J Med 355:488\u2013498. https:\/\/doi.org\/10.1056\/nejmra055289","journal-title":"New Engl J Med"},{"key":"2975_CR96","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1067\/mva.2003.66","volume":"37","author":"AG Passerini","year":"2003","unstructured":"Passerini AG, Milsted A, Rittgers SE (2003) Shear stress magnitude and directionality modulate growth factor gene expression in preconditioned vascular endothelial cells. J Vasc Surg 37:182\u2013190. https:\/\/doi.org\/10.1067\/mva.2003.66","journal-title":"J Vasc Surg"},{"key":"2975_CR97","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1111\/jth.13793","volume":"15","author":"A Chandrashekar","year":"2017","unstructured":"Chandrashekar A, Garry J, Gasparis A, Labropoulos N (2017) Vein wall remodeling in patients with acute deep vein thrombosis and chronic postthrombotic changes. J Thromb Haemost 15:1989\u20131993. https:\/\/doi.org\/10.1111\/jth.13793","journal-title":"J Thromb Haemost"},{"key":"2975_CR98","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.thromres.2015.06.024","volume":"136","author":"A Rabinovich","year":"2015","unstructured":"Rabinovich A, Cohen JM, Kahn SR (2015) Predictive value of markers of inflammation in the postthrombotic syndrome: a systematic review inflammatory biomarkers and PTS. Thromb Res 136:289\u2013297. https:\/\/doi.org\/10.1016\/j.thromres.2015.06.024","journal-title":"Thromb Res"},{"key":"2975_CR99","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1111\/j.1538-7836.2012.04798.x","volume":"10","author":"AC Bouman","year":"2012","unstructured":"Bouman AC, Smits JJM, Cate HT, Cate-Hoek AJT (2012) Markers of coagulation, fibrinolysis and inflammation in relation to post\u2010thrombotic syndrome. J Thromb Haemost 10:1532\u20131538. https:\/\/doi.org\/10.1111\/j.1538-7836.2012.04798.x","journal-title":"J Thromb Haemost"},{"key":"2975_CR100","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1007\/pl00002934","volume":"44","author":"NJ Morrish","year":"2001","unstructured":"Morrish NJ, Wang S-L, Stevens LK et al (2001) Mortality and causes of death in the WHO multinational study of vascular disease in diabetes. Diabetologia 44:S14. https:\/\/doi.org\/10.1007\/pl00002934","journal-title":"Diabetologia"},{"key":"2975_CR101","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2337\/dc10-1206","volume":"34","author":"S Colagiuri","year":"2011","unstructured":"Colagiuri S, Lee CMY, Wong TY et al (2011) Glycemic thresholds for Diabetes-Specific Retinopathy. Diabetes Care 34:145\u2013150. https:\/\/doi.org\/10.2337\/dc10-1206","journal-title":"Diabetes Care"},{"key":"2975_CR102","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1056\/nejmoa0802987","volume":"358","author":"AC Group","year":"2008","unstructured":"Group AC, Patel A, MacMahon S et al (2008) Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358:2560\u20132572. https:\/\/doi.org\/10.1056\/nejmoa0802987","journal-title":"N Engl J Med"},{"key":"2975_CR103","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1056\/nejmoa0808431","volume":"360","author":"W Duckworth","year":"2009","unstructured":"Duckworth W, Abraira C, Moritz T et al (2009) Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 360:129\u2013139. https:\/\/doi.org\/10.1056\/nejmoa0808431","journal-title":"N Engl J Med"},{"key":"2975_CR104","doi-asserted-by":"publisher","unstructured":"Group A to CCR in DS, Gerstein HC, Miller ME et al (2008) Effects of Intensive Glucose Lowering in Type 2 Diabetes. N Engl J Med 358:2545\u20132559. https:\/\/doi.org\/10.1056\/nejmoa0802743","DOI":"10.1056\/nejmoa0802743"},{"key":"2975_CR105","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12933-017-0515-9","volume":"16","author":"K Kearney","year":"2017","unstructured":"Kearney K, Tomlinson D, Smith K, Ajjan R (2017) Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk. Cardiovasc Diabetol 16:34. https:\/\/doi.org\/10.1186\/s12933-017-0515-9","journal-title":"Cardiovasc Diabetol"},{"key":"2975_CR106","doi-asserted-by":"publisher","unstructured":"Collaborators G C of, Roth D, Abate GA (2017) D, (2018) Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392:1736\u20131788. https:\/\/doi.org\/10.1016\/s0140-6736(18)32203-7","DOI":"10.1016\/s0140-6736(18)32203-7"},{"key":"2975_CR107","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/ndt\/gft209","volume":"29","author":"J Lutz","year":"2014","unstructured":"Lutz J, Menke J, Sollinger D et al (2014) Haemostasis in chronic kidney disease. Nephrol Dial Transpl 29:29\u201340. https:\/\/doi.org\/10.1093\/ndt\/gft209","journal-title":"Nephrol Dial Transpl"},{"key":"2975_CR108","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.ahj.2012.09.003","volume":"164","author":"PE Drawz","year":"2012","unstructured":"Drawz PE, Baraniuk S, Davis BR et al (2012) Cardiovascular risk assessment: addition of CKD and race to the Framingham equation. Am Hear J 164:925\u2013931e2. https:\/\/doi.org\/10.1016\/j.ahj.2012.09.003","journal-title":"Am Hear J"},{"key":"2975_CR109","doi-asserted-by":"publisher","first-page":"c171","DOI":"10.1159\/000325669","volume":"119","author":"A Chang","year":"2011","unstructured":"Chang A, Kramer H (2011) Should eGFR and Albuminuria be added to the Framingham risk score chronic kidney Disease and Cardiovascular Disease Risk Prediction. Nephron Clin Pr 119:c171\u2013c178. https:\/\/doi.org\/10.1159\/000325669","journal-title":"Nephron Clin Pr"},{"key":"2975_CR110","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1161\/atvbaha.120.314514","volume":"40","author":"N Mackman","year":"2020","unstructured":"Mackman N, Antoniak S, Wolberg AS et al (2020) Coagulation abnormalities and thrombosis in patients infected with SARS-CoV-2 and other Pandemic viruses. Arter Thromb Vasc Biology 40:2033\u20132044. https:\/\/doi.org\/10.1161\/atvbaha.120.314514","journal-title":"Arter Thromb Vasc Biology"},{"key":"2975_CR111","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1182\/bloodadvances.2021004816","volume":"6","author":"M Wygrecka","year":"2021","unstructured":"Wygrecka M, Birnhuber A, Seeliger B et al (2021) Altered fibrin clot structure and dysregulated fibrinolysis contribute to thrombosis risk in severe COVID-19. Blood Adv 6:1074\u20131087. https:\/\/doi.org\/10.1182\/bloodadvances.2021004816","journal-title":"Blood Adv"},{"key":"2975_CR112","doi-asserted-by":"publisher","first-page":"e219","DOI":"10.1111\/ijlh.13881","volume":"44","author":"N Lee","year":"2022","unstructured":"Lee N, Wang J, Brook R et al (2022) The evaluation of overall hemostatic potential assay in patients with COVID-19 infection. Int J Lab Hematol 44:e219\u2013e223. https:\/\/doi.org\/10.1111\/ijlh.13881","journal-title":"Int J Lab Hematol"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-024-02975-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-024-02975-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-024-02975-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T09:14:47Z","timestamp":1720516487000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-024-02975-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,22]]},"references-count":112,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["2975"],"URL":"https:\/\/doi.org\/10.1007\/s11239-024-02975-2","relation":{},"ISSN":["1573-742X"],"issn-type":[{"type":"electronic","value":"1573-742X"}],"subject":[],"published":{"date-parts":[[2024,4,22]]},"assertion":[{"value":"28 March 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}